Cargando…
Stroke Prevention in Atrial Fibrillation: Where are We Now?
Atrial fibrillation is the commonest arrhythmia worldwide and is a growing problem. AF is responsible for 25% of all strokes, and these patients suffer greater mortality and disability. Warfarin has traditionally been the only successful therapy for stroke prevention, but its limitations have result...
Autores principales: | Ahmad, Yousif, Lip, Gregory Y.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296491/ https://www.ncbi.nlm.nih.gov/pubmed/22408371 http://dx.doi.org/10.4137/CMC.S8976 |
Ejemplares similares
-
Stroke Prevention in Atrial Fibrillation: Concepts and Controversies
por: Ahmad, Yousif, et al.
Publicado: (2012) -
Emerging Tools for Stroke Prevention in Atrial Fibrillation
por: Voukalis, Christos, et al.
Publicado: (2016) -
Stroke and Bleeding Risk Assessment in Atrial Fibrillation: Where Are We Now?
por: Kuo, Ling, et al.
Publicado: (2021) -
Atrial Fibrillation after Cardiac Surgery: Where are we now?
por: Patel, Dimpi, et al.
Publicado: (2008) -
Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients
por: Li, Yan-Guang, et al.
Publicado: (2018)